Related Experiment Video
Updated: Mar 17, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Classification of Pulmonary Hypertension.
1Division of Cardiology, Department of Medicine, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Pulmonary hypertension (PH) classification defines subtypes based on clinical and physiological factors. Understanding these classifications is crucial for accurate diagnosis, treatment, and improved patient outcomes in PH management.
Area of Science:
- Cardiology
- Pulmonology
- Medical Classification Systems
Background:
- Pulmonary hypertension (PH) is a complex condition with diverse underlying causes.
- Accurate classification of PH is essential for effective patient management.
- Previous classification schemes have evolved to better reflect clinical understanding.
Purpose of the Study:
- To outline the current classification system for pulmonary hypertension (PH).
- To emphasize the importance of PH classification in clinical practice.
- To guide healthcare professionals in diagnosing and managing PH.
Main Methods:
- Review of established medical literature and clinical guidelines on PH classification.
- Analysis of the five defined groups of PH.
- Discussion of the clinical presentation, physiology, and treatment implications for each group.
Main Results:
- Five distinct groups of pulmonary hypertension have been defined.
- The classification scheme has undergone refinement to enhance clinical utility.
- Understanding the classification impacts treatment strategies and patient prognosis.
Conclusions:
- The classification of pulmonary hypertension is a dynamic system vital for diagnosis and management.
- A thorough understanding of PH subtypes is paramount for initiating appropriate patient work-up.
- Effective management and improved outcomes in PH are directly linked to accurate classification.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Heart Failure IV: Classification and Diagnostic Evaluation
Pulmonary Embolism I: Introduction

